Literature DB >> 8232103

Renal hemodynamic consequences of hyperlipidemia.

N Bank1.   

Abstract

Short-term dietary induced hypercholesterolemia in animals has been found to cause either increased vascular tone in various blood vessels, such as coronary arteries and renal vasculature, or impaired relaxation to endothelial-dependent vasodilators. In the kidney, renal blood flow, glomerular filtration rate and ultrafiltration coefficient are decreased whereas glomerular capillary pressure is elevated. These findings indicate pre- and post-glomerular constriction and mesangial cell contraction. Most evidence indicates that oxidized low density lipoprotein (ox-LDL) is responsible for initiating these functional abnormalities, and that it affects the endothelium rather than vascular smooth muscle cells. Nitric oxide (NO) and prostaglandin production are increased, probably due to the effects of ox-LDL on endothelial cell membranes. Vasoconstrictor prostaglandins and accelerated inactivation of NO by reactive oxygen species appear to play important roles in the impaired relaxation response. These endothelial abnormalities are postulated to contribute to progressive glomerulosclerosis via local hemodynamic changes and/or direct effects on mesangial cell proliferation and matrix synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232103

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  2 in total

1.  Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

Authors:  Ladan Zand; Vicente E Torres; Timothy S Larson; Bernard F King; Sanjeev Sethi; Eric J Bergstralh; Andrea Angioi; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2015-11-27       Impact factor: 5.992

2.  Increased nitric oxide and attenuated diastolic blood pressure variability in african americans with mildly impaired renal function.

Authors:  Keith M Diaz; Deborah L Feairheller; Kathleen M Sturgeon; Praveen Veerabhadrappa; Sheara T Williamson; Deborah L Crabbe; Michael D Brown
Journal:  Int J Hypertens       Date:  2011-01-09       Impact factor: 2.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.